These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22694950)

  • 1. Prediction of kidney-related outcomes in patients with type 2 diabetes.
    Jardine MJ; Hata J; Woodward M; Perkovic V; Ninomiya T; Arima H; Zoungas S; Cass A; Patel A; Marre M; Mancia G; Mogensen CE; Poulter N; Chalmers J;
    Am J Kidney Dis; 2012 Nov; 60(5):770-8. PubMed ID: 22694950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
    Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Charlton-Menys V; DeMicco DA; Fuller JH;
    Am J Kidney Dis; 2009 Nov; 54(5):810-9. PubMed ID: 19540640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS).
    Jia W; Gao X; Pang C; Hou X; Bao Y; Liu W; Wang W; Zuo Y; Gu H; Xiang K
    Nephrol Dial Transplant; 2009 Dec; 24(12):3724-31. PubMed ID: 19617258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
    Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
    Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
    J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes.
    Cooper ME; Perkovic V; McGill JB; Groop PH; Wanner C; Rosenstock J; Hehnke U; Woerle HJ; von Eynatten M
    Am J Kidney Dis; 2015 Sep; 66(3):441-9. PubMed ID: 25960304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria.
    Ito H; Takeuchi Y; Ishida H; Antoku S; Abe M; Mifune M; Togane M
    Nephrol Dial Transplant; 2010 Apr; 25(4):1161-7. PubMed ID: 19892756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.
    Tanaka N; Babazono T; Takagi M; Yoshida N; Toya K; Nyumura I; Hanai K; Uchigata Y
    Nephrology (Carlton); 2015 Aug; 20(8):531-8. PubMed ID: 25773273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients.
    Ando M; Yanagisawa N; Ajisawa A; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2011 Dec; 26(12):3923-9. PubMed ID: 21427068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study.
    Keane WF; Zhang Z; Lyle PA; Cooper ME; de Zeeuw D; Grunfeld JP; Lash JP; McGill JB; Mitch WE; Remuzzi G; Shahinfar S; Snapinn SM; Toto R; Brenner BM;
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):761-7. PubMed ID: 17699284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men.
    Nerpin E; Ingelsson E; Risérus U; Sundström J; Larsson A; Jobs E; Jobs M; Hallan S; Zethelius B; Berglund L; Basu S; Arnlöv J
    Nephrol Dial Transplant; 2011 Sep; 26(9):2820-7. PubMed ID: 21335440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
    Bakris GL; Weir MR; Shanifar S; Zhang Z; Douglas J; van Dijk DJ; Brenner BM;
    Arch Intern Med; 2003 Jul; 163(13):1555-65. PubMed ID: 12860578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: the DEMAND study.
    Rossi MC; Nicolucci A; Pellegrini F; Comaschi M; Ceriello A; Cucinotta D; Giorda C; Pomili B; Valentini U; Vespasiani G; De Cosmo S
    Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):110-6. PubMed ID: 19447588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes.
    Bouchi R; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Hanai K; Tanaka N; Ishii A; Iwamoto Y
    Hypertens Res; 2010 Oct; 33(10):1000-3. PubMed ID: 20613763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
    Bleyer AJ; Sedor JR; Freedman BI; O'Brien A; Russell GB; Graley J; Schelling JR
    Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between chronic kidney disease and silent cerebral infarction in patients with Type 2 diabetes.
    Bouchi R; Babazono T; Yoshida N; Nyumura I; Toya K; Hayashi T; Hanai K; Tanaka N; Ishii A; Iwamoto Y
    Diabet Med; 2010 May; 27(5):538-43. PubMed ID: 20536949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease.
    Solomon SD; Lin J; Solomon CG; Jablonski KA; Rice MM; Steffes M; Domanski M; Hsia J; Gersh BJ; Arnold JM; Rouleau J; Braunwald E; Pfeffer MA;
    Circulation; 2007 Dec; 116(23):2687-93. PubMed ID: 18025537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.